Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
PRLD holding history
Prelude Therapeutics Inc in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PRLD overviewAll 13F holders of PRLDFull Q2 2026 holdings
- Shares (Q2 2026)
- 281,200
- Value
- $1.50M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 281,200 | $1.50M | <0.1% | +6,000+2.2% | Added | Holders |
| Q1 2026 | 275,200 | $941.2K | <0.1% | +3,900+1.4% | Added | Holders |
| Q4 2025 | 271,300 | $786.8K | <0.1% | −272,700−50.1% | Reduced | Holders |
| Q3 2025 | 544,000 | $783.4K | <0.1% | −37,800−6.5% | Reduced | Holders |
| Q2 2025 | 581,800 | $470.9K | <0.1% | −74,900−11.4% | Reduced | Holders |
| Q1 2025 | 656,700 | $504.3K | <0.1% | +22,200+3.5% | Added | Holders |
| Q4 2024 | 634,500 | $809.0K | <0.1% | +437,600+222.2% | Added | Holders |
| Q3 2024 | 196,900 | $407.6K | <0.1% | −9,700−4.7% | Reduced | Holders |
| Q2 2024 | 206,600 | $787.1K | <0.1% | −38,200−15.6% | Reduced | Holders |
| Q1 2024 | 244,800 | $1.16M | <0.1% | +28,400+13.1% | Added | Holders |
| Q4 2023 | 216,400 | $924.0K | <0.1% | +77,026+55.3% | Added | Holders |
| Q3 2023 | 139,374 | $431.0K | <0.1% | −43,926−24.0% | Reduced | Holders |
| Q2 2023 | 183,300 | $825.0K | <0.1% | +44,800+32.3% | Added | Holders |
| Q1 2023 | 138,500 | $789.0K | <0.1% | +2,000+1.5% | Added | Holders |
| Q4 2022 | 136,500 | $824.0K | <0.1% | −6,900−4.8% | Reduced | Holders |
| Q3 2022 | 143,400 | $948.0K | <0.1% | −17,086−10.6% | Reduced | Holders |
| Q2 2022 | 160,486 | $838.0K | <0.1% | +120,386+300.2% | Added | Holders |
| Q1 2022 | 40,100 | $277.0K | <0.1% | −87,100−68.5% | Reduced | Holders |
| Q4 2021 | 127,200 | $1.58M | <0.1% | +127,200 | New | Holders |